Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wise

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
Clinical Pharmacology and Therapeutics|March 7, 2003
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersMichael H Skinner, Han-Yi Kuan, Alan Pan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 2012
The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazoleMosun A Ayan-Oshodi, Brian A Willis, William F Annes, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Journal of Medicinal Chemistry|October 1, 1987
1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agentsL D Wise, D E Butler, H A DeWald, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Plant Cell Reports|November 22, 2024
Next-generation marker-free transplastomic plants: engineering the chloroplast genome without integration of marker genes in Solanum tuberosum (potato)Alessandro Occhialini, Andrew C Reed, Stacee A Harbison, et al.
Journal of Medicinal Chemistry|September 9, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, S R Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Clinical Pharmacology|September 16, 2003
A review and assessment of potential sources of ethnic differences in drug responsivenessThorir D Bjornsson, John A Wagner, Stephen R Donahue, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
Clinical Pharmacology and Therapeutics|March 7, 2003
Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersMichael H Skinner, Han-Yi Kuan, Alan Pan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 2012
The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazoleMosun A Ayan-Oshodi, Brian A Willis, William F Annes, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Journal of Medicinal Chemistry|October 1, 1987
1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agentsL D Wise, D E Butler, H A DeWald, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Plant Cell Reports|November 22, 2024
Next-generation marker-free transplastomic plants: engineering the chloroplast genome without integration of marker genes in Solanum tuberosum (potato)Alessandro Occhialini, Andrew C Reed, Stacee A Harbison, et al.
Journal of Medicinal Chemistry|September 9, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, S R Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Clinical Pharmacology|September 16, 2003
A review and assessment of potential sources of ethnic differences in drug responsivenessThorir D Bjornsson, John A Wagner, Stephen R Donahue, et al.
Pageof 37